Cargando…

Occurrence of MYD88L265P and CD79B mutations in diffuse large b cell lymphoma with bone marrow infiltration: A case report

BACKGROUND: Over the past 20 years, we have gained a deep understanding of the biological heterogeneity of diffuse large B cell lymphoma (DLBCL) and have developed a range of new treatment programs based on the characteristics of the disease, bringing us to the era of immune-chemotherapy. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wen-Ye, Weng, Zhi-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372833/
https://www.ncbi.nlm.nih.gov/pubmed/36158496
http://dx.doi.org/10.12998/wjcc.v10.i22.7994